Gentherm Blanketrol III Model 233 Recall Over 115V CPU Board Overheating

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Gentherm Medical, LLC is recalling 9,714 units of Blanketrol III Model 233 thermal regulating systems due to potential overheating of the 115V CPU board causing device shutdown.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 10, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Overheating of the 115V CPU board may cause the device to shut down.", distributed worldwide - us nationwide distribution including in the territories of puerto rico, and the countries of brazil, canada, chile, colombia, costa rica, el salvador, guatemala, mexico, republic of panama, saudi arabia, taiwan, thailand, bahamas, and trinidad and tobago.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.

What Happened

Gentherm Medical, LLC initiated a voluntary recall of the Blanketrol III, Model 233 thermal regulating system after determining that overheating of the 115V CPU board may cause the device to shut down.

Which Products Are Affected

The recall covers 9,714 units of Blanketrol III, Model 233 distributed nationwide in the United States including Puerto Rico and to the countries of Brazil, Canada, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Mexico, Republic of Panama, Saudi Arabia, Taiwan, Thailand, Bahamas, and Trinidad and Tobago. Affected units have UDI codes 1061303186102, 1061303186107, 1061303186139, 1061303187107, 1061303187307 and serial numbers 131-2-00580 through 262-3-20277. The FDA recall number is Z-2970-2026 and the classification is Class II.

What You Should Do

The recall is ongoing. Consumers with questions should refer to the recalling firm Gentherm Medical, LLC or the FDA for additional guidance.

Why This Matters

This Class II recall involves nearly 10,000 thermal regulating devices distributed across the United States and multiple international markets.

Source

FDA recall Z-2970-2026, Gentherm Medical, LLC, Blue Ash, OH.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Gentherm Medical, LLC is recalling 9,714 units of Blanketrol III Model 233 thermal regulating systems due to potential overheating of the 115V CPU board causing device shutdown.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How is this recall classified, and why does that matter?
The FDA classifies this as a Class II recall, citing "Overheating of the 115V CPU board may cause the device to shut down." as the reason. Class I is the most serious (reasonable probability of serious harm), Class II is a moderate or temporary health risk, and Class III is unlikely to cause harm.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.